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Summary The relationship between breast self examination (BSE) and breast cancer stage at diagnosis was
examined in 616 women aged 15-59 years. Differences in tumour characteristics between those not practising
BSE and those practising but not taught were small and inconstant. However, women who had both practised
and had been taught BSE had more favourable tumours than the non-practising group. The difference was
most marked in terms of tumour size and the involvement of axillary nodes. The proportions of women in the
non-BSE and taught-BSE groups with each characteristic were respectively: size <2cm 33% and 45%, T1
clinical stage 27% and 42%, and No pathological stage 37% and 50%. This advantage to taught-BSE women
persisted after adjustment for the identified confounding factors of age, social class and oral contraceptive
use. The likely impact on breast cancer mortality is difficult to assess, although the potential benefit of the
lead time gained must not be ignored when assessing the costs and benefits of BSE.
The promising results of the recently reported Swedish trial
of mammography (Tabar et al., 1985), and the subsequent
discussion of the need for widespread population screening,
have encouraged critical review of the available methods for
the early detection of breast cancer. Breast self examination
(BSE) has not escaped scrutiny, and a number of recent
articles have stressed its disadvantages and emphasised the
limited evidence for its effectiveness. Frank and Mai (1985),
for example, argue that BSE may lead to unwarranted
anxiety, to the risk of false reassurance, and to unnecessary
medical investigation, particularly in younger women.
Unfortunately, no randomised controlled trial of the effect
of BSE on the prognosis of breast cancer is available; it is,
however, possible to assess whether BSE leads to the
diagnosis of breast cancer at an earlier stage. This, of course,
is neither a sufficient, nor strictly a necessary, condition for
a reduction in mortality, although the case for BSE would be
difficult to sustain if no effect on stage at diagnosis could be
demonstrated.
This question has been approached by a number of
investigators. An early study by Greenwald et al. (1978)
compared stage at diagnosis in cancers detected by BSE, by
physician examination and by 'accident'. However, as the
ability of a woman to detect a breast lump 'accidentally' is
obviously not independent of her practice of regular
systematic BSE, subsequent studies have compared stage at
diagnosis of self-discovered cancers in women who report
practising systematic BSE and in those who do not,
irrespective of how the cancer was detected. The difficulty of
defining 'systematic BSE' retrospectively, and the existence
of confounding factors, must explain some of the variation
in the results. Thus, three centres in the United States have
reported case series in which BSE has been associated with
favourable tumour characteristics and earlier stage at
diagnosis (Foster et al., 1978; Feldman et al., 1981; Huguley
and Brown 1981; Foster & Constanza, 1984), while
conversely, two case series have been presented in which no
significant advantage was demonstrated (Smith et al., 1980;
Senie et al., 1981). We report findings from our own study
here.
Subjects and methods
Between September 1980 and December 1984, all married
women (including those separated, widowed or divorced),
aged 16-59 years, newly presenting with breast cancer at six
London hospitals (Charing Cross, Guy's, Middlesex, Mount
Vernon, Royal Free, University College) were interviewed by
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specially trained nurses as part of a large case-control study
of the relationship between reproductive factors and breast
cancer (McPherson et al., 1983; Vessey et al., 1983). Some of
these patients had attended only the hospital at which they
were interviewed, while others had been referred in for
radiotherapy from other hospitals in the London area.
Each woman was asked about her medical, gynaecological,
obstetric, menstrual, contraceptive and social history. In
addition, the opportunity was taken to make enquiries about
who discovered the breast tumour and about whether or not
the woman normally practised BSE. Those responding
positively were asked whether or not they had been taught
how to do BSE and how often they examined themselves.
Women were not asked to demonstrate their proficiency at
BSE.
Subsequently, the case notes of each patient with cancer
were reviewed by a nurse and pre-operative clinical infor-
mation was abstracted to enable the tumour to be staged
according to the TNM system (International Union Against
Cancer, 1968). When different parts of the clinical record
reported different findings, those which were least favourable
were noted. Records made by medical students (when recog-
nisable as such) were ignored unless it was clear that they
were endorsed by a doctor. The nurse concerned with the
review (Moya Simmonds) had been carefully instructed by
one of us (M.V.) and a series of case-notes had been double-
coded (i.e. by M.V. and M.S.) to ensure that the work was
done as accurately as possible. The record review was done
many months after the interview had been completed, and
the interview data were not available to the abstractor. The
nurse also abstracted the pathological records (a) to confirm
that the lesion was indeed malignant and (b) to discover
whether or not there was histological evidence of axillary
node involvement. Information recorded by the pathologist
was not, of course, taken into account in the clinical staging.
A total of 747 women was interviewed. Of these 44 (5.9%)
were excluded from the analysis because the cancer had been
discovered by someone other than the woman herself.
Staging information was obtained for 616 (87.1%) of the
remaining 707 women. Our failure to obtain the necessary
information for 91 women was due in part to missing case
notes and in part to inadequate clinical information in some
of the notes which were found. There were however, no
important differences between the 616 women for whom
staging was completed and the 91 women for whom it was
not with regard to BSE history, age, oral contraceptive use
or social class.
Results
The relationship between the BSE history given by the
G
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Table I Clinical characteristics of breast tumour at presentation in relation to





Tumour Done but Monthly or
characteristics Not done not taught <Monthly more often Total
Size .2cm 33.2 34.4 43.6 45.3 37.5
Skin of breast
normal 68.0 64.6 75.6. 71.5 69.3
Nipple normal 86.7 89.6 86.6 88.9 87.7
No deep
attachment 93.9 92.7 97.6 95.8 94.6
Ti 27.2 26.0 40.2 41.7 32.1
Stage 1 66.0 61.5 70.7 70.8 67.0
Axillary nodes not
palpable (No) 74.1 71.8 79.3 80.6 76.0
Number of women
in BSE group 294 96 82 144 616
The discrepancy in the results for T1 tumours and for Stage 1 tumours reflects
the fact that the effect of BSE is primarily on the T1/T2 ratio - i.e. the increase in
T1 tumours is compensated for by a reduction in T2 tumours rather than in T3 or
T4 tumours.





Axillary Done but Monthly or
nodes Not done not taught <Monthly more often Total
(a) Histologically negative 79 30 25 47 181
(b) Histologically positive 135 38 29 46 248
(c) No mention ofnodes
in report 80 28 28 51 187
Total 294 96 82 144 616
% negative, nodal
rlOOa) status known < > 36.9 44.1 46.3 50.5 42.2
La+bJ
% with no report of
positive nodes
I 54.1 60.4 64.6 68.1 59.7
a+b+c3
patient and the clinical characteristics of the tumour at
presentation (as abstracted from the case notes) is shown in
Table I. Differences in tumour characteristics between those
in the group not practising BSE and those in the practising
but not taught group were small and inconsistent. Women
who had been taught (and were practising) BSE, however,
had a higher proportion of tumours with favourable
characteristics than did women in the no BSE group. The
difference was most marked in relation to tumour size. There
was also a tendency for taught women examining their
breasts monthly or more often to have slightly more favour-
able tumours than taught women examining their breasts less
often than this.
Table II summarizes the available histopathological infor-
mation on involvement of the axillary nodes by disease.
Many pathologists' reports made no mention of the axillary
nodes; in these circumstances it was impossible to tell
whether no nodes had been submitted for examination or
whether nodes had been submitted and had been found to be
free of disease (we considered it very unlikely that the
pathologist would fail to report positive nodes). However, no
matter how the indeterminate category is handled, there is aBREAST SELF EXAMINATION AND CANCER STAGE 209






Done but Monthly or women in
Not done not taught <Monthly more often Total group
Age -39 43.5 11.1 16.7 28.7 100.0 108
40-49 47.1 14.8 12.7 25.4 100.0 244
50-59 50.0 18.2 12.5 19.3 100.0 264
Oral Never 50.6 17.8 11.7 19.9 100.0 377
contraceptive Past 42.8 12.2 16.2 28.8 100.0 198
use Current' 43.9 12.2 14.6 29.3 100.0 41
Social I 37.3 11.9 15.3 35.5 100.0 59
classb II-IIINM 46.4 16.7 16.3 20.6 100.0 209
(husband) IIIM-V 47.3 16.2 10.4 26.1 100.0 241
Other 57.0 14.0 13.1 15.9 100.0 107
aUse within year preceding diagnosis; bRegistrar-General's classification. Questions were asked only about
husband's occupation. The category 'other' includes no husband, students, armed forces.




Axillary nodes No report of
Size Skin Nipple No deep negative, nodal positive axillary
<2cm normal normal attachment T1 Stage 1 No status known nodes
Age -39 44.2 83.3 95.4 95.4 43.5 64.8 72.2 43.1 69.4
40-49 40.5 72.1 90.2 94.7 36.1 73.0 81.1 41.8 57.8
50-59 31.8 61.0 82.0 93.2 23.9 62.5 72.7 42.8 57.6
Oral Never 32.6 65.0 85.9 93.6 27.9 64.8 75.3 43.3 58.4
contraceptive Past 44.7 75.3 89.9 95.5 38.4 70.2 77.8 25.0 63.4
use Current 46.3 80.5 92.7 100.0 41.5 63.4 73.2 42.4 61.6
Social I 44.0 78.0 86.4 94.9 45.8 69.5 74.6 55.6 66.1
class II-IIINM 37.4 70.3 88.0 95.2 32.5 67.5 77.5 45.6 61.7
(husband) IIIM-V 35.9 69.7 86.7 94.2 30.3 65.6 73.9 37.4 55.6
Other 38.0 61.7 89.7 94.4 28.0 68.2 78.5 37.9 61.7
strong trend towards decreased axillary node involvement
across the BSE groups. This trend is much more in evidence
than is the trend concerning the clinical assessment of the
axillary nodes shown in Table I.
We wondered whether the association between BSE
history and tumour characteristics might be explained in
terms of confounding by some other variable. Accordingly,
we examined the effects of age, oral contraceptive use, social
class and body weight. The last mentioned variable was
found not to be a confounder but each of the other three
variables was. Table III shows the relationship between BSE
and age, oral contraceptive use and social class. As expected
younger women, oral contraceptive users and women of high
social class tended to have been taught BSE and to have
been practising it more often than other women. In Table
IV, the relationships between the same three confounding
variables and tumour characteristics are examined. Younger
women had tumours which were more favourable with
regard to all the characteristics shown save for the per-
centage in Stage I and the percentage classed No. Much the
same was true for oral contraceptive users. The pattern in
relation to social class was more variable, but women in
social class I were much less likely to have skin involvement
than other women and had much more favourable axillary
nodal findings on histological review (provided that only
those of known nodal status were considered).
We used an additive multiple logistic model to adjust the
data shown in Tables I and II for the effects of age, oral
contraceptive use and social class. The results obtained are
given in Table V. Although there is some reduction in the
association between BSE and favourable clinical tumour
characteristics, the data for size and for proportion of T1
tumours remain encouraging and the trends are highly
significant statistically. The figures also suggest a small
advantage of BSE in relation to axillary nodal status
assessed clinically. The data concerning the histopathological
assessment of the axillary nodes continue to indicate a strong
beneficial association with BSE.
Discussion
The clinical findings reported here depend on the staging of
tumours retrospectively from the data recorded in case notes,
a procedure which is known to be inaccurate. In a previous
study, however, using identical methods, we found case
record based staging to provide a good indication of
prognosis (see Greenberg et al., 1985). Thus, in a series of210 D. MANT et al.
Table V. Breast tumour characteristics in relation to practice of BSE. Data are adjusted percentages in





Tumour Done but Monthly or hetero- linear
characteristics Not done not taught <Monthly more often geneity trend
Clinical
Size <2cm 33.8 36.1 41.5 44.0 9.5a 9.3b
Skin of breast normal 68.6 66.0 74.2 68.9 3.3 0.3
Nipple normal 86.9 90.6 85.9 88.4 2.4 0.2
No deep attachment 94.3 93.4 97.6 96.0 4.9 2.3
Ti 28.0 27.8 38.0 39.7 17.5c 14.5c
Stage 1 66.0 62.1 70.2 70.4 4.1 2.2
Axillary nodes
not palpable (No) 74.1 72.4 78.6 81.8 7.3 5.7a
Pathological
Axillary nodes negative,
nodal status known 37.2 44.6 45.4 50.2 10.6a 10.1b
No report of positive
axillary nodes 54.5 61.7 64.0 67.8 16.6c 16.3c
ap<0.05; bp<0.01; cP<0.001.
Groupings used for age, oral contraceptive use and social class as shown in Tables Ill and IV.
Percentages adjusted to overall distribution for all 616 women (or 429 women for the analysis dealing with
those with axillary nodal status known).
654 women with breast cancer with long term follow up, the
10 year survival rate for the 162 with T1 No Mo tumours
was 72% and for the 212 with T2 No MO tumours was 59%.
For the 23 with T1 Ni MO and the 94 with T2 Ni MO
tumours, the survival rates were identical - both 46%. For
the 163 remaining women, the survival rate was 32%. We
thus consider our clinical data to be of prognostic value, but
we recognise that their inaccuracy would also tend to
obscure any association between BSE and early diagnosis.
Accordingly, the true relationship between BSE and
favourable clinical characteristics may well be greater than
that demonstrated.
It can, of course, be argued that the association between
BSE and favourable clinical tumour characteristics is not
necessarily causal (i.e. that women who say they were taught
and now practise BSE are for other reasons likely to present
with more favourable tumours than other women), but the
association remains after adjustment for identified con-
founding factors. Moreover, the case for a causal relation-
ship is supported by the demonstration of an incremental
effect of increasing degrees of implied effectiveness of BSE
on the strength of the association. Having said this, it must
be noted that the effect we have observed on clinical stage,
although highly significant statistically, is nonetheless
modest.
The results presented on the histopathological status of the
axillary nodes are even more encouraging, although here too
there must be some reservations about the adequacy of the
data. The greater apparent effect on histologically assessed
as against clinically assessed nodal status presumably reflects
the inaccuracy of the clinical staging method. This histo-
logical data suggest that properly taught BSE could lead to a
reduction of the order of 20-30% in the number of women
presenting with positive axillary nodes at the time of
diagnosis. It is plausible that an improvement in nodal status
of this magnitude could be associated with an important
increase in survival.
Our results are consistent with the five comparable studies
reported since 1980 of which we are aware, bearing in mind
that the definition of BSE and the non-BSE comparison
group has been inconsistent. The proportions of tumours
<2cm (or <2cm) in BSE and non-BSE groups in each
study, defining the BSE group as women who practice BSE
at least yearly (Huguley & Brown, 1981), several or more
times yearly (Feldman et al., 1981), ever (Foster &
Constanza, 1984), at least three times a year (Smith et al.,
1980), and at least monthly (Senie et al., 1981) were respec-
tively 47% vs. 37%, 56% vs. 39%, 42% vs. 23%, 23% vs.
22% and 48% vs. 43%. In the last two studies the observed
difference did not reach statistical significance. Two studies
of different design from the United Kingdom, reporting the
effect of a BSE booklet (Turner et al., 1984) and BSE
instruction (Philip et al., 1984), also described a reduction in
tumour size in the intervention group. The failure to show a
significant reduction in tumour size by Smith et al. may be
explained by the limited number of women (127) upon
whom the analysis was based. The study by Senie et al.
contained a high proportion (9%) ofmicroscopic tumours.
All the studies mentioned also reported axillary node
status based on pathological information. The degree of
ascertainment of nodal status varied (and was not reported
by Smith et al. and Feldman et al.). The proportions of
women with positive axillary nodes in BSE and non-BSE
groups (using the same definitions as before) were
respectively 43% and 50% (Huguley & Brown, 1981), 46%
and 61% (Feldman et al., 1981), 39% and 56% (Foster &
Constanza, 1984), 36% and 42% (Senie et al., 1981), and
41% and 42% (Smith et al., 1980). As before, the observed
difference in the latter two studies was not statistically
significant.
Our conclusion is that BSE, after adequate teaching, does
lead to earlier diagnosis. The clinical importance of this lead
time is hard to assess, but we are following up all the women
in our study and will be able to report on survival in dueBREAST SELF EXAMINATION AND CANCER STAGE 211
course. There is no doubt that the specificity of BSE as a
screening test is low and the costs in terms of false positive
results, anxiety, suffering and use of medical resources may
be high. The important question now is not whether BSE
advances diagnosis, but whether the benefit is sufficient to
outweigh the human and resource costs.
We would like to thank Moya Simmonds, Elizabeth Hilton and
Judith Young for interviewing the women with breast cancer and the
consultants at the participating hospitals for allowing us to include
patients under their care. The Imperial Cancer Research Fund
kindly provided financial support.
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